138
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Factors Affect the Eradication Rate of Helicobacter pylori by Modified Quadruple Therapy: A Prospective Cohort Study

, , , , &
Pages 2339-2345 | Published online: 29 Apr 2022

References

  • Sugano K. Screening of gastric cancer in Asia. Best practice & research. Clin Gastroenterol. 2015;29(6):895–905. doi:10.1016/j.bpg.2015.09.013
  • Khalilpour A, Kazemzadeh-narbat M, Tamayol A, et al. Biomarkers and diagnostic tools for detection of Helicobacter pylori. Appl Microbiol Biotechnol. 2016;100(11):4723–4734. doi:10.1007/s00253-016-7495-7
  • Sitas F. Twenty five years since the first prospective study by Forman et al. (1991) on Helicobacter pylori and stomach cancer risk. Cancer Epidemiol. 2016;41:159–164. doi:10.1016/j.canep.2016.02.002
  • Nagy P, Johansson S, Molloy-bland M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog. 2016;8:8. doi:10.1186/s13099-016-0091-7
  • Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514–533. doi:10.1111/apt.13497
  • Yuan G, Chen Y, He S. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(22):2171.
  • Mathew JM. H pylori eradication therapy reduces gastric cancer in patients with or without gastric neoplasia. Ann Intern Med. 2020;173(6):JC32. doi:10.7326/ACPJ202009150-032
  • Sassi F, Tamone C, D’amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018;10(11):1656. doi:10.3390/nu10111656
  • El Shahawy MS, Shady ZM, Gaafar A. Influence of adding vitamin D3 to standard clarithromycin-based triple therapy on the eradication rates of Helicobacter pylori infection. Arab J Gastroenterol. 2021;22(3):209–214. doi:10.1016/j.ajg.2021.08.002
  • Liu WZ, Xie Y, Lu H, et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.12475
  • Li Y, Lin R, Jin Y, et al. Genotyping Helicobacter pylori antibiotic resistance and virulence-associated genes in patients with gastric cancer in Wenzhou, China. Arab J Gastroenterol. 2021;22(4):267–271. doi:10.1016/j.ajg.2021.05.017
  • Rajavi Z, Sabbaghi H, Amini Sharifi E, et al. Comparison between patching and interactive binocular treatment in amblyopia: a randomized clinical trial. J Curr Ophthalmol. 2019;31(4):426–431. doi:10.1016/j.joco.2019.07.004
  • Antico A, Tozzoli R, Giavarina D, et al. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system. Clin Rev Allergy Immunol. 2012;42(3):355–364. doi:10.1007/s12016-011-8255-1
  • Yildirim O, Yildirim T, Seckin Y, et al. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017;26(9):1377–1381. doi:10.17219/acem/65430
  • Huang B, Yan S, Chen C, et al. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wien Klin Wochenschr. 2019;131(3–4):75–80. doi:10.1007/s00508-018-1416-y
  • El Shahawy MS, Hemida MH, El Metwaly I, et al. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open. 2018;2(6):270–275. doi:10.1002/jgh3.12081
  • Yang L, He X, Li L, et al. Effect of vitamin D on Helicobacter pylori infection and eradication: a meta-analysis. Helicobacter. 2019;24(5):1–7. doi:10.1111/hel.12655
  • Wanibuchi K, Hosoda K, Ihara M, et al. Indene compounds synthetically derived from vitamin D have selective antibacterial action on Helicobacter pylori. Lipids. 2018;53(4):393–401. doi:10.1002/lipd.12043
  • Han C, Ni Z, Yuan T, et al. Influence of serum vitamin D level on Helicobacter pylori eradication: a multi-center, observational, prospective and cohort study. J Dig Dis. 2019;20(8):421–426. doi:10.1111/1751-2980.12793
  • Knorr J, Ricci V, Hatakeyama M, et al. Classification of Helicobacter pylori virulence factors: is CagA a toxin or not? Trends Microbiol. 2019;27(9):731–738. doi:10.1016/j.tim.2019.04.010
  • Tohidpour A. CagA-mediated pathogenesis of Helicobacter pylori. Microb Pathog. 2016;93:44–55. doi:10.1016/j.micpath.2016.01.005
  • Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl 1):e12403. doi:10.1111/hel.12403
  • Padula W. Letter concerning vision therapy: ocular motor training in mild traumatic brain injury. Ann Neurol. 2021;89(4):847–848. doi:10.1002/ana.26026